FDA Adverse Event Malfunction Summary report: N

CSF-FLOW CONTROL SHUNT KIT CONTOURED REGULAR, MEDIUM PRESSURE

MDR report key: 8408633 · Received March 11, 2019

Report

Report Number
2021898-2019-00101
Event Type
Malfunction
Date Received
March 11, 2019
Date of Event
March 8, 2019
Report Date
June 3, 2019
Manufacturer
MEDTRONIC NEUROSURGERY
Product Code
JXG
UDI-DI
00643169466371
PMA / PMN Number
K841442
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THE RETURNED PRODUCT INCLUDED PART NUMBER (PN)13763-2 CONTOUR VALVE, PN 10028-1 VENTRICULAR CATHETER ON THE STYLET, AND PN 10027-1 C ARDIAC/PERITONEAL CATHETER. THE VALVE MET THE REQUIREMENTS FOR PATENCY, LEAK AND REFLUX TESTING. THE VALVE DID NOT MEET THE REQUIREMENTS FOR PRESSURE-FLOW AND P REIMPLANTATION TESTING. NINE INCHES OF THE VENTRICULAR CATHETER AND 35.5 INCHES OF THE CARDIAC/PERITONEAL CATHETER WAS RETURNED. THE CARDIAC PERITONEAL CATH ETER MEET THE REQUIREMENTS FOR LEAK, PATENCY, AND TENSILE TESTING. THE VENTRICULAR CATHETER MEET THE REQUIREMENTS FOR TENSILE TESTING. THE VENTRICULAR CATHETER DID NOT MEET THE REQUIREMENTS FOR LEAK AND PATENCY TESTING DUE TO FIVE CUTS IN THE CATHETER. IT IS UNKNOWN HOW OR WHEN THIS DAMAGE OCCURRED. THE INSTRUCTIONS FOR USE CAUTIONS, ¿LOW TEAR STRENGTH IS A CHARACTERISTIC OF MOST UNREINFORCED SILICONE ELASTOMER MATERIALS. CARE MUST BE TAKEN WITH THE HANDLING AND PLACEMENT OF THE SILICONE ELASTOMER CATHETER TUBING TO AVOID CUTS, NICK, OR TEARS.¿ THERE WAS PROTEINACEOUS DEBRIS ON THE VENTRICULAR CATHETER AND THE STYLET. THE INSTRUCTIONS FOR USE CAUTIONS, ¿SHUNT OBSTRUCTION MAY OCCUR IN ANY OF THE COMPONENTS OF THE SHUNT SYSTEM. THE SYSTEM MAY BECOME INTERNALLY OCCLUDED DUE TO TISSUE FRAGMENTS, BLOOD CLOTS, TUMOR CELL AGGREGATES, BACTERIAL COLONIZATION OR OTHER DEBRIS.¿ ALL VALVES AND CATHETERS ARE 100% INSPECTED AT THE TIME OF MANUFACTURE. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THE DEVICE WAS FOUND TO BE BROKEN WHEN OPENING THE PACKAGING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
200279 CSF-FLOW CONTROL SHUNT KIT CONTOURED REGULAR, MEDIUM PRESSURE SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS JXG MEDTRONIC NEUROSURGERY 9003 E E05849 00643169466371

Patients

Seq Age Sex Outcome Treatment
1